The Expression and Significance of Squamous cell Antigen in Cervical Cancer Treated by Concurrent Chemo-Radiotherapy

CHEN Wen-juan,PAN Jian-ji,JIANG N
DOI: https://doi.org/10.15912/j.cnki.gocm.2013.22.489
2013-01-01
Abstract:Objective To investigate the significance and expression of the serum squamous cell carcinoma antigen(Scc-Ag) in the advanced stage cervical squamous carcinoma treated by concurrent chemo-radiotherapy.Methods From 2008 August to 2011 August we collected 84 cases of stage ⅡA-ⅣB cervical squamous carcinoma patients before and after concurrent chemo-radiotherapy,and The follow-up 3 to 6 months later after treatment of serum specimens,all serum specimens were SCC-Ag detection.According to the stage of the International Federation of gynecology and Obstetrics(FIGO): ⅡA stage in 6 cases,33 cases of ⅡB,ⅢA in 7 cases,ⅢB in 32 cases and 7 cases of stage Ⅳ.Pelvic lymph node was positive in 50 cases.Results The positive rate of SCC-Ag is 80.95%(68/84) which SCC-Ag more than 30ng/mL was in 12 cases,20ng/mL<SCC<30 ng/mL in 18 cases.Pelvic lymph node positive rate was 59.5%(50/84)),SCC-Ag was relevant with the clinical stages and lymph node metastasis(P<0.05).The SCC detection according to the stage of: ⅡA,ⅡB,ⅢA,ⅢB-ⅣA were 50%,79.4%,85.7% and 86.7% respectively before chemo radiation;SCC positive rate of 0.17.6%.14.3%.43.2% respectively after treatment which significant difference(P<0.05).Conclusion SCC-Ag is a relatively good method for the detection of disease recurrence in patients with cervical cancer who were treated by concurrent chemo-radiotherapy.
What problem does this paper attempt to address?